Purdue Pharma Presents Educational Session on Abuse-Deterrent Technology and Opioid Analgesics at PAINWeek

Purdue Pharma’s Vice President of Health Policy, Dr. J. David Haddox, will present an educational session today at PAINWeek’s annual conference, entitled:

Innovative Formulations Designed to Deter the Abuse of Opioid Analgesics:
Overview of Emerging Technologies


The Cosmopolitan
Brera Ballroom, Level 3, Las Vegas, NV


Thursday, September 4, 2014
2:50 pm – 3:50 pm

The prescription and illicit opioid abuse crisis is a multifaceted public health challenge, and as a manufacturer of prescription opioids, we have a responsibility to join the fight. At Purdue we are committed to lead our industry in helping address our nation's prescription and illicit opioid abuse crisis.

There is more to come – as we continue to work with partners and experts to deliver solutions. Below you will find additional information about our efforts.

Read our open letter about the opioid crisis.